Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2011 1
2012 6
2013 6
2014 4
2015 7
2016 4
2017 2
2018 6
2019 2
2020 1
2021 8
2022 6
2023 9
2024 5
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
[Neuromyelitis optica].
Kvistad SA, Wergeland S, Torkildsen Ø, Myhr KM, Vedeler CA. Kvistad SA, et al. Among authors: wergeland s. Tidsskr Nor Laegeforen. 2013 Oct 15;133(19):2057-61. doi: 10.4045/tidsskr.13.0608. Tidsskr Nor Laegeforen. 2013. PMID: 24129537 Free article. Review. Norwegian.
Discontinuation of dimethyl fumarate in multiple sclerosis - a nationwide study.
Roar M, Nielsen ARH, Berg JM, Sirakov G, Stilund M, Schäfer J, Ratzer R, Frederiksen J, Asgari N, Ashna SN, Jensen HB, Kant M, Theódorsdóttir Á, Illes Z, Sellebjerg F, Magyari M, Schlosser LM, Nordborg H, Wergeland S, Sejbaek T. Roar M, et al. Among authors: wergeland s. Mult Scler Relat Disord. 2023 Dec;80:105127. doi: 10.1016/j.msard.2023.105127. Epub 2023 Nov 5. Mult Scler Relat Disord. 2023. PMID: 37956521
Breastfeeding and treatment for multiple sclerosis.
Torkildsen Ø, Rød BE, Bø L, Wergeland S, Holmøy T, Myhr KM. Torkildsen Ø, et al. Among authors: wergeland s. Tidsskr Nor Laegeforen. 2022 Oct 24;142(15). doi: 10.4045/tidsskr.22.0529. Print 2022 Oct 25. Tidsskr Nor Laegeforen. 2022. PMID: 36286559 Free article. English, Norwegian.
The Norwegian Multiple Sclerosis Registry and Biobank.
Myhr KM, Grytten N, Torkildsen Ø, Wergeland S, Bø L, Aarseth JH. Myhr KM, et al. Among authors: wergeland s. Acta Neurol Scand. 2015;132(199):24-8. doi: 10.1111/ane.12427. Acta Neurol Scand. 2015. PMID: 26046555 Review.
BCG vaccination and multiple sclerosis risk: A Norwegian cohort study.
Nakken O, Aarseth JH, Wergeland S, Stigum H, Meyer HE, Holmøy T. Nakken O, et al. Among authors: wergeland s. Mult Scler. 2024 May;30(6):646-653. doi: 10.1177/13524585241230440. Epub 2024 Feb 27. Mult Scler. 2024. PMID: 38414125 Free PMC article.
The neuroprotective potential of mesenchymal stem cells from bone marrow and human exfoliated deciduous teeth in a murine model of demyelination.
Kråkenes T, Wergeland S, Al-Sharabi N, Mohamed-Ahmed S, Fromreide S, Costea DE, Mustafa K, Bø L, Kvistad CE. Kråkenes T, et al. Among authors: wergeland s. PLoS One. 2023 Nov 9;18(11):e0293908. doi: 10.1371/journal.pone.0293908. eCollection 2023. PLoS One. 2023. PMID: 37943848 Free PMC article. Clinical Trial.
The CLARION study: first report on safety findings in patients newly initiating treatment with cladribine tablets or fingolimod for multiple sclerosis.
Butzkueven H, Hillert J, Soilu-Hänninen M, Ziemssen T, Kuhle J, Wergeland S, Magyari M, Berger JR, Moore N, Aydemir A, Bezemer I, Sabidó M. Butzkueven H, et al. Among authors: wergeland s. Curr Med Res Opin. 2023 Oct;39(10):1367-1374. doi: 10.1080/03007995.2023.2256220. Epub 2023 Sep 7. Curr Med Res Opin. 2023. PMID: 37675878 Free article.
61 results